540359 — Parmax Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Parmax Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—
Source:	ARS	ARS	PRESS
Standards:	IAS	IAS	—
Status:	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	4.07	0.51	0.903
Net Total Accounts Receivable
Net Total Receivables	28.2	33.2	66
Total Inventory
Total Other Current Assets
Total Current Assets	75.3	57.7	100
Net Property, Plant And Equipment	95	93.8	79.7
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	176	153	188
Accounts Payable
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	71.4	92.1	130
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	118	153	207
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	58.6	0.709	-19.9
Total Liabilities & Shareholders' Equity	176	153	188
Total Common Shares Outstanding